Tigermed is a prominent Contract Research Organization (CRO) dedicated to delivering a full spectrum of clinical trial services across various healthcare sectors. With a strong commitment to advancing human health, Tigermed provides expertise in clinical development, medical device trials, IVD CRO services, and regulatory affairs. Their comprehensive offerings include preclinical development, real-world evidence studies, medical writing, clinical monitoring, and data management, ensuring clients receive extensive support throughout all phases of clinical research.

With a global presence, including over 180 offices across Asia, the United States, Europe, Latin America, and Africa, Tigermed is well-positioned to facilitate multi-region clinical trials and decentralized approaches. Their capabilities extend into specialized areas such as cell and gene therapy, oncology, and infectious diseases, backed by a skilled workforce of more than 10,000 professionals. Committed to corporate responsibility and sustainability, Tigermed continuously seeks to optimize clinical study outcomes and improve market access for innovative therapeutic solutions.